These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38170337)

  • 1. Interferon-Gamma-Inducible Protein 16 Inhibits Hepatocellular Carcinoma via Interferon Regulatory Factor 3 on Chemosensitivity.
    Lin W; Zhao Z; Du W; Ni Z; Pan C; Fang P; Li J; ZhuGe L; Jin S
    Dig Dis Sci; 2024 Feb; 69(2):491-501. PubMed ID: 38170337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosomes function as nanoparticles to transfer miR-199a-3p to reverse chemoresistance to cisplatin in hepatocellular carcinoma.
    Zhang K; Shao CX; Zhu JD; Lv XL; Tu CY; Jiang C; Shang MJ
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32463473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of
    Liu Z; Dang C; Xing E; Zhao M; Shi L; Sun J
    DNA Cell Biol; 2019 Nov; 38(11):1366-1373. PubMed ID: 31633393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial fission factor promotes cisplatin resistancein hepatocellular carcinoma.
    Li X; Wu Q; Ma F; Zhang X; Cai L; Yang X
    Acta Biochim Biophys Sin (Shanghai); 2022 Mar; 54(3):301-310. PubMed ID: 35538029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA FGD5-AS1 contributes to cisplatin resistance in hepatocellular carcinoma via sponging microRNA-153-3p by upregulating Twinfilin Actin Binding Protein 1 (TWF1).
    Yang Y; Shi L; Zhang D; Wu D; An Y; Zhang Y; Chen X
    Bioengineered; 2021 Dec; 12(1):6713-6723. PubMed ID: 34519634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of Linc00173 increases BCL2 mRNA stability via the miR-1275/PROCA1/ZFP36L2 axis and induces acquired cisplatin resistance of lung adenocarcinoma.
    Tao X; Li Y; Fan S; Wu L; Xin J; Su Y; Xian X; Huang Y; Huang R; Fang W; Liu Z
    J Exp Clin Cancer Res; 2023 Jan; 42(1):12. PubMed ID: 36627670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNA LEF1-AS1 acts as a microRNA-10a-5p regulator to enhance MSI1 expression and promote chemoresistance in hepatocellular carcinoma cells through activating AKT signaling pathway.
    Gao J; Dai C; Yu X; Yin XB; Zhou F
    J Cell Biochem; 2021 Jan; 122(1):86-99. PubMed ID: 32786108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ELF1 activated long non-coding RNA CASC2 inhibits cisplatin resistance of non-small cell lung cancer via the miR-18a/IRF-2 signaling pathway.
    Xiao XH; He SY
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3130-3142. PubMed ID: 32271431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of lncRNA KCNQ1OT1 on autophagy and drug resistance of hepatocellular carcinoma cells by targeting miR-338-3p.
    Zhong W; Dai Q; Huang Q
    Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):191-196. PubMed ID: 32538770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer-associated fibroblast exosomes promote chemoresistance to cisplatin in hepatocellular carcinoma through circZFR targeting signal transducers and activators of transcription (STAT3)/ nuclear factor -kappa B (NF-κB) pathway.
    Zhou Y; Tang W; Zhuo H; Zhu D; Rong D; Sun J; Song J
    Bioengineered; 2022 Mar; 13(3):4786-4797. PubMed ID: 35139763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silencing of miR-1246 Induces Cell Cycle Arrest and Apoptosis in Cisplatin-Resistant Ovarian Cancer Cells by Promoting ZNF23 Transcription.
    Cai L; Zhang Q; Du L; Zheng F
    Cytogenet Genome Res; 2021; 161(10-11):488-500. PubMed ID: 34923485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-21-5p Suppressed the Sensitivity of Hepatocellular Carcinoma Cells to Cisplatin by Targeting FASLG.
    Chen S; Yang C; Sun C; Sun Y; Yang Z; Cheng S; Zhuge B
    DNA Cell Biol; 2019 Aug; 38(8):865-873. PubMed ID: 31225740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA FAM13A-AS1, transcriptionally regulated by PHOX2B, modulates hepatocellular carcinoma chemoresistance via stabilizing PPARγ.
    Ye D; Ma J; Yu T; Ran F; Zha Y
    Gene; 2023 Aug; 877():147570. PubMed ID: 37330023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IFI16 restoration in hepatocellular carcinoma induces tumour inhibition via activation of p53 signals and inflammasome.
    Lin W; Zhao Z; Ni Z; Zhao Y; Du W; Chen S
    Cell Prolif; 2017 Dec; 50(6):. PubMed ID: 28990231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nutlin-3-induced redistribution of chromatin-bound IFI16 in human hepatocellular carcinoma cells in vitro is associated with p53 activation.
    Shi XL; Yang J; Mao N; Wu JH; Ren LF; Yang Y; Yin XL; Wei L; Li MY; Wang BN
    Acta Pharmacol Sin; 2015 Feb; 36(2):252-8. PubMed ID: 25544361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low‑intensity ultrasound enhances the chemosensitivity of hepatocellular carcinoma cells to cisplatin via altering the miR‑34a/c‑Met axis.
    Li P; Zhang J; Li F; Yu Y; Chen Y
    Int J Mol Med; 2019 Jul; 44(1):135-144. PubMed ID: 31115495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-183 overexpression inhibits tumorigenesis and enhances DDP-induced cytotoxicity by targeting MTA1 in nasopharyngeal carcinoma.
    Wang G; Wang S; Li C
    Tumour Biol; 2017 Jun; 39(6):1010428317703825. PubMed ID: 28631568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. circ-LDLRAD3 Knockdown Reduces Cisplatin Chemoresistance and Inhibits the Development of Gastric Cancer with Cisplatin Resistance through miR-588 Enrichment-Mediated SOX5 Inhibition.
    Liang Q; Chu F; Zhang L; Jiang Y; Li L; Wu H
    Gut Liver; 2023 May; 17(3):389-403. PubMed ID: 35975639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of ATOH8 Increases Stem Cell Features of Hepatocellular Carcinoma Cells.
    Song Y; Pan G; Chen L; Ma S; Zeng T; Man Chan TH; Li L; Lian Q; Chow R; Cai X; Li Y; Li Y; Liu M; Li Y; Zhu Y; Wong N; Yuan YF; Pei D; Guan XY
    Gastroenterology; 2015 Oct; 149(4):1068-81.e5. PubMed ID: 26099525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of METTL14-mediated m
    Gong S; Wang S; Shao M
    J Mol Med (Berl); 2022 Dec; 100(12):1771-1785. PubMed ID: 36352154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.